Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 688-332-8 | CAS number: 199119-58-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Eye irritation
Administrative data
- Endpoint:
- eye irritation: in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 6 May 1997 to 23 May 1997
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: The study was performed to GLP and in line with standardised guidelines OECD 405, EU Method B.5 and EPA OPP 81-4 with no deviations thought to impact on the reliability of the presented results.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 997
- Report date:
- 1997
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 405 (Acute Eye Irritation / Corrosion)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.5 (Acute Toxicity: Eye Irritation / Corrosion)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPP 81-4 (Acute Eye Irritation)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: J-MAFF 59 NohSan No. 4200
- Deviations:
- no
- GLP compliance:
- yes
Test material
- Reference substance name:
- sodium 4,6-dimethoxy-N-({[3-(2,2,2-trifluoroethoxy)pyridin-2-yl]sulfonyl}carbamoyl)pyrimidin-2-aminide
- EC Number:
- 688-332-8
- Cas Number:
- 199119-58-9
- Molecular formula:
- C14H13F3N5O6SNa
- IUPAC Name:
- sodium 4,6-dimethoxy-N-({[3-(2,2,2-trifluoroethoxy)pyridin-2-yl]sulfonyl}carbamoyl)pyrimidin-2-aminide
- Test material form:
- solid: particulate/powder
- Details on test material:
- - Physical state: solid
- Storage condition of test material: room temperature
Constituent 1
Test animals / tissue source
- Species:
- rabbit
- Strain:
- New Zealand White
- Details on test animals or tissues and environmental conditions:
- TEST ANIMALS
- Age at study initiation: approximately 18-24 weeks
- Weight at study initiation: 3660 - 4610 g
- Housing: individually
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21 ± 2 ºC
- Humidity (%): 55 ± 10 %
- Air changes (per hr): approximately 13-14 air changes per hour
- Photoperiod: 12 hours light / 12 hours dark
IN-LIFE DATES: From 6 May 1997 to 23 May 1997
Test system
- Vehicle:
- unchanged (no vehicle)
- Controls:
- no
- Amount / concentration applied:
- TEST MATERIAL
- Amount applied: 0.1 mL test material, weighing approximately 66 mg - Duration of treatment / exposure:
- - Duration of treatment: 24 hours
- Frequency of administration: One single dose
- Dose administration: Approximately 66 mg of the test material was applied into the conjunctival sac of the left eye of each rabbit by gently pulling the lower lid away from the eyeball. The lids were then gently held together for about 1 second. The right eye remained untreated and served as a control. - Observation period (in vivo):
- Animals were observed up to 10 days post administration
- Number of animals or in vitro replicates:
- 3 males and 3 females (6 animals in total)
- Details on study design:
- REMOVAL OF TEST SUBSTANCE
- Washing: Treated eyes were gently washed with distilled water for 1 minute after the reading at 24 hours post-treatment
SCORING SYSTEM:
The reactions observed were scored in line with the grading system in accordance with the OECD/EEC/MAFF scoring system outlined in the field “Any other information on materials and methods incl. Tables”.
TOOL USED TO ASSESS SCORE: To aid scoring, animals were examined using a portable, hand-held slit lamp.
OBSERVATIONS: Mortality and clinical signs were checked daily, and any remarkable findings were recorded. Bodyweights were measured and recorded immediately before dose administration, at the 72-hour examination, and on days 7 and 10.
Results and discussion
In vivo
Resultsopen allclose all
- Irritation parameter:
- cornea opacity score
- Basis:
- mean
- Time point:
- 24/48/72 h
- Score:
- 0.2
- Max. score:
- 4
- Reversibility:
- fully reversible within: 10 days
- Irritation parameter:
- iris score
- Basis:
- mean
- Time point:
- 24/48/72 h
- Score:
- 0
- Max. score:
- 2
- Reversibility:
- fully reversible
- Irritation parameter:
- conjunctivae score
- Basis:
- mean
- Time point:
- 24/48/72 h
- Score:
- 1.7
- Max. score:
- 3
- Reversibility:
- fully reversible within: 10 days
- Irritation parameter:
- chemosis score
- Basis:
- mean
- Time point:
- 24/48/72 h
- Score:
- 0.9
- Max. score:
- 4
- Reversibility:
- fully reversible within: 10 days
- Irritant / corrosive response data:
- Scattered areas of corneal opacity were seen in a total of three animals, one at the 1-hour examination only, one at 1 and 24 hours, and one at 24, 48 and 72 hours. Moderate hyperemia of the iris was noted for five animals, only at the 1-hour reading. Diffuse, crimson-coloured conjunctival redness (scores of 2) was observed in the treated eyes of all animals after 1 hour, and diminished by day 7 to scores of 1 or were clear. Conjunctival redness was clear in all animals by day 10. All animals also exhibited above-normal swelling of the eyelids and nicitating membranes, or obvious swelling with partial eversion of the eyelids, beginning 1 hour after treatment. Conjunctival chemosis was reversed within 48 or 72 hours, or 7 days. All eye reactions were reversed by day 10.
- Other effects:
- There was no mortality during the test and no remarkable clinical signs were observed. Slight bodyweight losses were noted for one male and one female at day 3 and one female at day 7. However, these changes were not considered to be related to treatment.
Any other information on results incl. tables
Table 2: Irritation Scores
Animal no |
Males |
Females |
||||
607 |
615 |
791 |
418 |
382 |
394 |
|
CORNEA |
||||||
1 hour |
1 |
0 |
0 |
0 |
0 |
1 |
1 day |
1 |
0 |
1 |
0 |
0 |
0 |
2 days |
0 |
0 |
1 |
0 |
0 |
0 |
3 days |
0 |
0 |
1 |
0 |
0 |
0 |
7 days |
0 |
0 |
0 |
0 |
0 |
0 |
10 days |
0 |
0 |
0 |
0 |
0 |
0 |
IRIS |
||||||
1 hour |
1 |
1 |
1 |
0 |
1 |
1 |
1 day |
0 |
0 |
0 |
0 |
0 |
0 |
2 days |
0 |
0 |
0 |
0 |
0 |
0 |
3 days |
0 |
0 |
0 |
0 |
0 |
0 |
7 days |
0 |
0 |
0 |
0 |
0 |
0 |
10 days |
0 |
0 |
0 |
0 |
0 |
0 |
CONJUNCTIVAL REDNESS |
||||||
1 hour |
2 |
2 |
2 |
2 |
2 |
2 |
1 day |
2 |
2 |
2 |
1 |
2 |
2 |
2 days |
2 |
2 |
2 |
1 |
2 |
1 |
3 days |
1 |
1 |
1 |
1 |
1 |
1 |
7 days |
1 |
1 |
1 |
0 |
1 |
0 |
10 days |
0 |
0 |
0 |
0 |
0 |
0 |
CONJUNCTIVAL CHEMOSIS |
||||||
1 hour |
2 |
1 |
1 |
1 |
1 |
2 |
1 day |
2 |
1 |
1 |
1 |
1 |
1 |
2 days |
1 |
1 |
1 |
1 |
1 |
0 |
3 days |
0 |
1 |
1 |
1 |
1 |
0 |
7 days |
0 |
0 |
0 |
0 |
0 |
0 |
10 days |
0 |
0 |
0 |
0 |
0 |
0 |
Table 3: Mean scores of the 24, 48 and 72 hours observations
Animal No. |
607 |
615 |
791 |
418 |
382 |
394 |
Total (mean of 24, 48 and 72 hours) |
Observation |
Males |
Females |
|||||
Cornea |
0.3 |
0 |
1 |
0 |
0 |
0 |
0.2 |
Iris |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Conjunctival redness |
1.7 |
2 |
2 |
1 |
2 |
1.3 |
1.7 |
Conjunctival chemosis |
1 |
1 |
1 |
1 |
1 |
0.3 |
0.9 |
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Under the conditions of the study, the test material did not elicit any reactions, in any of the animals, during the course of the study indicating that the test material is not an eye irritant. The study is considered to be reliable, relevant and adequate for risk assessment and classification and labelling purposes.
- Executive summary:
The eye irritation potential of the test material was determined in accordance with standardised guidelines OECD 405, EU Method B.5 and EPA OPP 81-4. Approximately 66 mg of test material was instilled into the conjunctival sac of one eye of six rabbits; the second eye served as a control. The test eyes were gently washed with distilled water 24 hours after treatment. Eyes were examined for irritation at 1, 24, 48 and 72 hours and 7 and 10 days after treatment.
Scattered areas of corneal opacity were seen in a total of three animals, one at the 1-hour examination only, one at 1 and 24 hours, and one at 24, 48 and 72 hours. Moderate hyperemia of the iris was noted for five animals, only at the 1-hour reading. Diffuse, crimson-coloured conjunctival redness (scores of 2) was observed in the treated eyes of all animals after 1 hour, and diminished by day 7 to scores of 1 or were clear. Conjunctival redness was clear in all animals by day 10. All animals also exhibited above-normal swelling of the eyelids and nicitating membranes, or obvious swelling with partial eversion of the eyelids, beginning 1 hour after treatment. Conjunctival chemosis was reversed within 48 or 72 hours, or 7 days. All eye reactions were reversed by day 10. There was no mortality, and no remarkable clinical observations. Slight bodyweight losses were noted for one male and two females.
Under the conditions of the study, the test material does not require classification for eye irritation in line with Regulation No. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.